[Intensive combined therapy of patients with urogenital tuberculosis].
More rapid attenuation of urogenital inflammation achieved in 41.65% of nephrophthiasis patients treated with combination levorin + furadonin + nitroxoline compared to control illustrates the validity of introducing tuberculostatic--potentiating drugs in chemotherapy of urogenital tuberculosis.
Soloveĭ
B V
BV
Soloveĭ
T P
TP
D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002174:Candicidin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D009582:Nitrofurantoin / Q000627:therapeutic use*; D009600:Nitroquinolines / Q000627:therapeutic use*; D016896:Treatment Outcome; D014401:Tuberculosis, Urogenital / Q000188:drug therapy*
D000892:Anti-Infective Agents, Urinary; D000995:Antitubercular Agents; D009600:Nitroquinolines; D002174:Candicidin; D009582:Nitrofurantoin; C005308:nitroxoline
Opyt intensifikatsii kombinirovannogo lecheniia bolńykh mochepolovym tuberkulezom.